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euronal polarity is, at least in part, mediated by the
differential sorting of membrane proteins to distinct
 
domains, such as axons and somata/dendrites.
We investigated the pathways underlying the subcellular
targeting of NgCAM, a cell adhesion molecule residing
on the axonal plasma membrane. Following transport of
NgCAM kinetically, surprisingly we observed a transient
appearance of NgCAM on the somatodendritic plasma
membrane. Down-regulation of endocytosis resulted in loss
of axonal accumulation of NgCAM, indicating that the axonal
N
 
localization of NgCAM was dependent on endocytosis. Our
data suggest the existence of a dendrite-to-axon transcytotic
pathway to achieve axonal accumulation. NgCAM mutants
with a point mutation in a crucial cytoplasmic tail motif
(YRSL) are unable to access the transcytotic route. Instead,
they were found to travel to the axon on a direct route.
Therefore, our results suggest that multiple distinct pathways
operate in hippocampal neurons to achieve axonal accumu-
lation of membrane proteins.
 
Introduction
 
Cellular polarity is a fundamental property of most eukaryotic
cells and is intricately linked to cellular function. One of the
mechanisms underlying cell polarity is the differential sorting
of membrane proteins to distinct plasma membrane domains
on the biosynthetic route from the Golgi apparatus (Craig
and Banker, 1994; Mellman, 1995; Winckler and Mellman,
1999). Polarized membrane traffic is best understood in
epithelial cells, which have long served as the paradigm for
similar studies in other mammalian cell types (Mellman,
1995; Mostov and Cardone, 1995; Folsch et al., 1999;
Mostov et al., 2003). In the epithelial Madin-Darby canine
kidney (MDCK) cell line, most membrane proteins destined
for either the apical or basolateral domains are sorted directly
in the TGN into two distinct vesicle populations (Wandinger-
Ness et al., 1990). Not all epithelial cells use the TGN as the
main sorting station for polarized cargo. In contrast to
MDCK cells, another epithelial cell type, hepatocytes,
transport almost all membrane proteins first to the basolateral
surface. Only after internalization into endosomes does
sorting of apical and basolateral membrane proteins take
place. In hepatocytes then, apical proteins travel to the apical
domain by an indirect, transcytotic pathway via the basolateral
domain rather than on a direct route from the TGN (Tuma
and Hubbard, 2003).
Much less is known about polarized membrane traffic in
neurons. Dotti and Simons (1990) suggested that the apical
domain of MDCK cells is equivalent to the axonal domain
of cultured hippocampal neurons, and that the basolat-
eral domain of MDCK cells is equivalent to the somatoden-
dritic domain. This hypothesis was based on the observation
that the basolateral vesicular stomatitis virus glycoprotein
(VSVG) was sorted to the somatodendritic domain, and
the apical influenza HA protein to the axonal domain.
Therefore, the signals and the machineries recognizing
them might be largely conserved between epithelial cells
and cultured hippocampal neurons for apical/axonal and
basolateral/somatodendritic transport. Indeed, transport of
transmembrane proteins to the somatodendritic domain is
mediated by cytoplasmic tail signals, which are frequently
closely related to basolateral targeting determinants (West
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et al., 1997; Jareb and Banker, 1998; but see also Cheng
et al., 2002).
Travel to the axon is less well understood (Winckler and
Mellman, 1999) and might not be strictly conserved (Colman,
1999). Similarly to MDCK cells, extracellular/transmembrane
domains are important for axonal targeting of at least some
proteins (e.g., amyloid precursor protein [Tienari et al., 1996]
and NgCAM [Sampo et al., 2003]). On the other hand, exog-
enously expressed apical proteins are often found uniformly on
axons and dendrites rather than polarized to the axon (Jareb
and Banker, 1998). In many studies, the interpretation of re-
sults is complex because exogenous expression of the protein
leads to axonal localization, but the protein is additionally
found brightly in all or part of the soma and dendrites (Jareb
and Banker, 1998; Stowell and Craig, 1999; Francesconi and
Duvoisin, 2002). Whether this reflects an inability of neurons
Figure 1. NgCAM is found in somatodendritic 
endosomes positive for transferrin. (A) Hippo-
campal neurons were infected with AdNgCAM for 
24 h, fixed, and stained with a sandwich protocol 
to detect intracellular (red) and cell surface (green) 
pools of NgCAM. The axon is marked with arrows, 
dendrites with arrowheads. Single channel images 
of the boxed regions are shown in B (B1 and B2, 
axon; B3 and B4, dendrite). Intracellular NgCAM 
is red (B1 and B3) and cell surface NgCAM is 
green (B2 and B4). (C) Hippocampal neurons were 
infected with AdNgCAM for 24 h and incubated 
live with FITC–transferrin (green) for 30 min at 37 C 
before fixation. Cells were stained according to the 
sandwich protocol using anti-NgCAM antibodies 
and different secondary antibodies. Surface NgCAM 
was detected with a blue secondary Ab, showing 
axonal restriction of surface NgCAM (arrows mark 
the axon; this cell is bi-axonal). The axon appears 
magenta colored because of the overlap of blue 
and red. The internal NgCAM pool was detected 
with a red secondary Ab. (D) The insets show the 
soma region of the same cell processed with a 
thresholding program (Adobe Photoshop
®) to 
show the simultaneous presence of transferrin 
(green; D1) and intracellular NgCAM (red; D2) in 
some endocytic compartments. Overlap appears 
yellow in D3. A representative, single confocal 
section is shown.T
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to read and execute the same signals or is primarily due to mis-
sorting because of high overexpression is unclear.
In contrast, the axonal localization of the adhesion mole-
cule NgCAM is preserved even upon exogenous overexpres-
sion in a high percentage of expressing neurons (Vogt et al.,
1996; Jareb and Banker, 1998; Winckler et al., 1999).
Therefore, the mechanisms underlying axonal targeting of
NgCAM (the chick homologue of L1) have been investi-
gated in several studies (Kamiguchi and Lemmon, 1998;
Burack et al., 2000; Sampo et al., 2003). Experiments using
live imaging of NgCAM–EGFP demonstrated that Ng-
CAM–EGFP-containing intracellular vesicles are not polar-
ized to axons but rather found well into dendrites as well as
axons (Burack et al., 2000). Surface NgCAM at steady
state, on the other hand, is highly enriched on the axonal
surface and largely absent from the soma and dendrites.
Based on these observations, Burack et al. (2000) proposed
that transport of post-Golgi NgCAM-containing vesicles
occurs nondiscriminately into both axons and dendrites,
and that the polarized surface distribution arises from selec-
tive and preferential fusion of NgCAM vesicles with the ax-
onal plasma membrane.
An alternative model for achieving steady-state axonal en-
richment was proposed by Garrido et al. (2001) based on ex-
periments with an axonally enriched voltage-gated sodium
channel (VGNC) chimera. Axonal localization of VGNC
chimeras was dependent on an endocytosis motif that medi-
ated preferential internalization from the somatodendritic
domain, thereby leading to net enrichment on the axonal
surface. The axonal accumulation of VAMP2 was similarly
dependent on an endocytosis signal (Sampo et al., 2003).
Thus, VAMP2 might localize primarily to the axon because
of preferential somatodendritic removal.
Recently, Sampo et al. (2003) further investigated the ax-
onal targeting of NgCAM and found that NgCAM internal-
ization from the somatodendritic surface was largely unde-
tectable, except in a small subpopulation of cells. Therefore,
they proposed that NgCAM is sorted to the axon by selec-
tive axonal fusion and not by preferential somatodendritic
removal. However, direct positive evidence supporting this
model is still lacking, and many questions concerning the
axonal trafficking pathway of NgCAM remain unanswered.
In this work, we test these different models more directly by
analyzing the transport pathways involved in axonal tar-
geting of NgCAM kinetically. Our data suggest a model
in which NgCAM can travel to the axon by a new path-
way, i.e., via dendrite-to-axon transcytosis. Additionally, we
found that signals required for the transcytotic pathway are
encoded in NgCAM’s cytoplasmic tail. Deletions of crucial
regions in the cytoplasmic tail of NgCAM result in mutant
proteins that are unable to access the transcytotic pathway
and travel instead directly from the TGN to the axon. Our
data suggest that hippocampal neurons possess both transcy-
totic and direct axonal sorting pathways.
 
Results
 
NgCAM is present in somatodendritic endosomes
 
Previously, intracellular organelles containing EGFP–Ng-
CAM were found in dendrites and somata as well as axons at
steady state (Burack et al., 2000). After infection of cells
with a defective adenovirus encoding NgCAM (AdNg-
CAM) for 24 h, we visualized internal and surface pools of
NgCAM with different fluorophores using a sandwich pro-
tocol (Kamiguchi and Lemmon, 2000). We similarly find
NgCAM in intracellular somatodendritic compartments
(Fig. 1, A and B3) as well as in intracellular compartments in
the axon (Fig. 1, A and B1). The surface pool of NgCAM,
on the other hand, is highly enriched on the axon (Fig. 1, A,
B2, and B4). Next, we quantified the extent of cell surface
polarization of NgCAM using IP software to determine a
“polarity index” (PI) similar to that used by others (Cheng et
al., 2002; Sampo et al., 2003; see Materials and methods for
details). Uniform staining gives a PI value of 1, whereas ax-
Figure 2. Quantification of axonal 
localization of NgCAM and NgCAM 
mutants. NgCAM constructs are depicted 
as schematics. The 114-aa cytoplasmic 
tail of NgCAM is numbered from the first 
residue of the cytoplasmic tail, Lys1. The 
ankyrin binding domain is indicated by an 
orange box. The YRLS motif is indicated 
by a black bar. A PI was determined as 
described in the Materials and methods 
by dividing the axonal by the dendritic 
average pixel intensities. Uniform staining 
gives a PI value of around 1. Preferential 
axonal staining gives a PI value of  1, 
whereas preferential somatodendritic 
enrichment gives a PI value of  1. The 
average PI ( SD) is indicated for wild-
type NgCAM, the somatodendritic LDLR, 
and two NgCAM mutants, N(CT3) and 
NgCAM(Y33A).T
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onal enrichment gives a PI value of 
 
 
 
1, and somatoden-
dritic enrichment gives a PI value of 
 
 
 
1. For virally ex-
pressed NgCAM, the PI is 6.0, indicating sixfold axonal
enrichment (Fig. 2).
We first wanted to test whether some of these somatoden-
dritic compartments containing NgCAM are endosomes.
To this end, we again infected cells with AdNgCAM for 24 h.
Subsequently, live cells were incubated with FITC–trans-
ferrin for 30 min before fixation. Transferrin is a recycling
ligand that is taken up into early and recycling endosomes
but is largely excluded from late endosomes and lysosomes
(Mellman, 1995). The cell surface and intracellular pools of
NgCAM were differentially stained and analyzed by confo-
cal fluorescence microscopy (Fig. 1 C). A subset of the
intracellular vesicular profiles of NgCAM present in the
somatodendritic domain colocalized with internalized trans-
ferrin (Fig. 1 D; yellow indicates overlap), suggesting that
some of the somatodendritic compartments containing
NgCAM are endosomes.
Next, we asked whether NgCAM reached these somato-
dendritic endosomes via the cell surface or by direct trans-
port from the TGN. Thus, we assayed NgCAM uptake by
incubating cells expressing NgCAM with antibodies to Ng-
CAM’s extracellular domain for 30 min before fixation. Cell
surface and internalized antibodies were then differentially
stained using the sandwich protocol with only secondary an-
tibodies. We found that surface NgCAM was restricted to
the axon (blue), while internalized anti-NgCAM antibodies
(red) were detected in the somatodendritic domain in
 
 
 
50% of NgCAM-expressing cells (Fig. 3, A and B). Unin-
fected control cells did not have detectable staining even af-
ter 2 h of incubation with anti-NgCAM antibodies, indicat-
ing that nonspecific uptake of antibodies was negligible
(unpublished data).
To further characterize the compartments that accumulate
internalized NgCAM, we incubated neurons infected with
AdNgCAM with both anti-NgCAM antibodies and FITC–
transferrin for 30 min before fixation. We find that internal-
ized NgCAM colocalizes to a significant extent (
 
 
 
60% of
profiles) with internalized FITC–transferrin (Fig. 3 B; yel-
low indicates overlap) in the soma. Taken together, these
observations suggest that NgCAM on the cell surface can
reach early/recycling endosomes in the somatodendritic
membrane domain.
 
Inhibition of endocytosis disrupts axonal localization 
of NgCAM
 
Our observations raised the possibility that NgCAM is inter-
nalized from the somatodendritic domain. To test whether
endocytosis was necessary for axonal accumulation of Ng-
CAM, we down-regulated endocytosis by expressing a dom-
inant-negative dynamin1(K44A) (Seeger and Payne, 1992;
Damke et al., 1995; Schmid et al., 2000; Fourgeaud et al.,
2003). The extent of down-regulation of endocytosis by dy-
namin(K44A) is dependent on its expression levels, so that
in cells expressing low amounts of dynamin(K44A), endocy-
tosis will be inhibited only partially, whereas in cells express-
ing large amounts of dynamin(K44A), endocytosis will be
inhibited more completely. If NgCAM were directly in-
serted into the axonal plasma membrane, it would not a pri-
ori depend on endocytosis for axonal localization and would
therefore be expected to be unaffected by coexpression of dy-
namin(K44A). In contrast, if NgCAM had to be selectively
removed from the somatodendritic surface for axonal accu-
mulation, high levels of dynamin(K44A) expression would
compromise axonal polarization.
Cells were infected with a recombinant adenovirus encod-
ing dynamin(K44A) for several hours before either transfec-
tion with a plasmid encoding NgCAM or infection with Ad-
NgCAM. Cells were fixed 20 h later and stained against
surface NgCAM and internal dynamin(K44A). We observed
a significant change in the distribution of NgCAM in cells
expressing dynamin(K44A). A representative experiment is
shown in Fig. 4 A. The percentage of cells that expressed
NgCAM preferentially on the axonal surface decreased dra-
matically, while the proportion of uniformly expressing cells
increased. This observation suggests that endocytosis is a
necessary step for axonal accumulation of NgCAM. Surpris-
ingly, we also observed a novel population of cells (
 
 
 
20%)
expressing NgCAM primarily on the somatodendritic do-
Figure 3. NgCAM is internalized into a transferrin-positive 
somatodendritic compartment. (A) Hippocampal neurons were 
infected with AdNgCAM for 24 h and incubated live with both 
FITC–transferrin (green) and anti-NgCAM antibodies for 30 min at 
37 C before fixation. Cells were stained according to the sandwich 
protocol using only secondary antibodies. The surface-bound 
antibodies were detected with a Cy5-labeled secondary Ab (blue), 
showing axonal restriction of surface NgCAM (arrows mark the 
axon). Internalized antibodies were detected with Alexa
®568-labeled 
secondary Ab (red). Internalized NgCAM (red) was detected in the 
axonal growth cone and along the axon (arrows) as well as in the 
soma. Uptake of FITC–transferrin can only be detected in the soma 
and dendrites (arrowheads). (B) Single channel images of the soma 
region of the same cell are shown processed with a thresholding 
program to show the simultaneous presence of transferrin (green; B1) 
and internalized NgCAM (red; B2) in some endocytic compartments. 
Overlap appears yellow in B3. A representative, single confocal 
section is shown.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 
Axonal targeting pathways |
 
 Wisco et al. 1321
 
main, i.e., showing reversed polarity (Fig. 4, C and C’). Fur-
thermore, this population was only observed in cells express-
ing high levels of dynamin(K44A), but never in control cells.
As is the case with dominant-negative approaches in general,
the extent of inhibition is dependent on the expression level
of the dominant-negative protein. In accordance with this,
we observe no effects of low levels of dynamin(K44A) on ax-
onal localization of NgCAM (Fig. 4, B and B’). At high lev-
els of dynamin(K44A) expression where endocytosis was
most likely effectively blocked, NgCAM accumulated on the
somatodendritic domain (Fig. 4, C and C’).
 
Following the transport kinetics of NgCAM
 
Our observation of somatodendritically enriched NgCAM
raised the possibility that NgCAM is first targeted to the so-
matodendritic surface, reinternalized, and then transcytosed
to the axon. We therefore decided to study the kinetics of
NgCAM transport from the TGN to the plasma membrane.
To this end, we applied a pulse-chase approach making use
of the secretion inhibitor brefeldin A (BFA) (Chardin and
McCormick, 1999). BFA is a highly specific blocker of
Arf1-dependent membrane transport in both the Golgi
and endosomes, and its effects are readily reversible in all
cell types studied, including cultured hippocampal neurons
(Craig and Banker, 1994; Cid-Arregui et al., 1995; Jareb
and Banker, 1997). As retrograde Golgi transport is still ac-
tive in the presence of BFA, Golgi membranes and associ-
ated proteins flow back into the ER, forming a hybrid ER/
Golgi compartment (Klausner et al., 1992). Membrane pro-
teins, including newly synthesized NgCAM, accumulate in
the ER/Golgi compartment during BFA treatment and fail
to reach the plasma membrane (unpublished data). As the
BFA block is reversible, a wave of transport of the accumu-
lated membrane proteins can be observed after removal of
BFA (i.e., “pulse”). The progress of this pulse can be ob-
served by fixing the cells after intervals following BFA wash-
out (i.e., “chase”).
We infected neuronal cultures with AdNgCAM for 4 h,
treated overnight with BFA to stop Golgi trafficking,
washed the BFA away, and fixed the cells at various intervals
thereafter. Internal and surface pools of NgCAM were dif-
ferentially stained as before. Strikingly, surface expression of
NgCAM was first detectable on the somatodendritic do-
main, i.e., with reversed polarity (Fig. 5 A). Cells with soma-
todendritic NgCAM were also observed when the primary
antibody was added to live cells (unpublished data) and then
fixed, rather than after fixation without permeabilization.
Indeed, 4 h after washing out BFA, 30% of infected cells ex-
pressed NgCAM with reversed polarity (Fig. 5 B, circles),
while most of the rest (67%) showed only intracellular stain-
ing (Fig. 5 B, diamonds, stippled line). Of the cells with de-
tectable surface expression at 4 h of chase, 92% show soma-
todendritic restriction of NgCAM. This somatodendritic
pool could then be quantitatively chased to the axonal
plasma membrane over time (Fig. 5 B, squares). These ob-
servations suggest that during biosynthetic transport from
the Golgi, NgCAM is first inserted into the somatodendritic
plasma membrane.
To corroborate this unexpected finding, an alternative
pulse-chase assay was used that avoided the use of BFA. Af-
ter infection with AdNgCAM, membrane traffic was ar-
rested by incubating the cells at 19
 
 
 
C for 12 h (Scales et al.,
1997). Subsequently, the cells were warmed to 37
 
 
 
C to al-
low membrane traffic to proceed (“pulse”), and then the
cells were fixed at several time intervals after warming
Figure 4. Inhibition of endocytosis leads to loss of axonal 
polarization of NgCAM. (A) Neuronal cultures expressing NgCAM 
in the presence (gray bars; DNdynamin) or absence (black bars; 
control) of dominant-negative dynamin (DN-dynamin[K44A]) were 
stained, and the localization of NgCAM quantified. A representative 
experiment is shown. (B and B’) Example of a neuron expressing 
NgCAM (B) and low levels of DN-dynamin(K44A) (B’). NgCAM 
remains axonally enriched. (C and C’) Example of a neuron that 
expresses NgCAM (C) and high levels of DN-dynamin(K44A) (C’). 
NgCAM accumulates on soma and dendrites (arrowheads) and is 
largely absent from the axon (arrows).T
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(“chase”). We obtained qualitatively similar results with this
second approach: after arrest of membrane traffic and subse-
quent release, NgCAM was first detected on the cell surface
in the somatodendritic domain (Fig. 5 C). Again, this popu-
lation could be chased to the axon over time. The kinetics of
axonal appearance are somewhat faster after cold block re-
lease than after BFA block release. This is likely an indica-
tion that the Golgi block is more readily reversed after cold
treatment than after BFA treatment, resulting in a tighter
chase of NgCAM to the surface.
We also wanted to see if we could detect somatodendritic
NgCAM without using any TGN transport block. There-
fore, we fixed and stained AdNgCAM-infected cells at early
time points after infection (21 h), when NgCAM first ap-
peared at the cell surface. Surface expression was low at this
point, and only 
 
 
 
25% of infected neurons had any detect-
able surface expression at all. We could detect a small per-
centage of cells with somatodendritic enrichment of Ng-
CAM (unpublished data). We therefore consider it unlikely
that the initial somatodendritic surface appearance is an arti-
fact caused by the use of BFA. Rather, our kinetic data sug-
gest that NgCAM first appears at the somatodendritic sur-
face and not at the axonal membrane domain.
Furthermore, quantitative analysis of multiple cells at
short times after BFA release with IP software showed that
in cells with “somatodendritic/reversed polarity” (Fig. 5 B,
circles), 
 
 
 
80% of the fluorescence signal is on the soma-
todendritic domain. The initial somatodendritic delivery
therefore appears to be the predominant pathway followed
by the majority of NgCAM molecules leaving the TGN and
not a minor salvage pathway traveled by only a small per-
centage of missorted molecules. Based on these findings, we
propose the following model for NgCAM delivery to the
axon: (1) NgCAM travels from the TGN primarily to the
somatodendritic plasma membrane, (2) the protein is inter-
nalized, and (3) NgCAM traffics from somatodendritic en-
dosomes to the axonal plasma membrane by transcytosis.
 
Direct and indirect axonal pathways exist
 
We next sought to determine the regions of NgCAM that
contain the trafficking signals necessary for transcytosis. Nu-
merous studies have demonstrated that the cytoplasmic tail
of NgCAM contains signals important for trafficking and
localization of the molecule (Kamiguchi and Lemmon,
1998; Kamiguchi et al., 1998). Thus we generated a trun-
cated NgCAM construct, NgCAM(CT3), lacking all but
three amino acids of its cytoplasmic tail (Fig. 2). Neuronal
cultures were simultaneously infected with AdNgCAM
(CT3) and Adp75NGFR. P75NGFR is present on both
axons and dendrites and serves to visualize both axonal and
somatodendritic domains (Fig. 6 A, inset). We found that
NgCAM(CT3) is axonally enriched at steady state (Fig. 2;
Fig. 6 A), indicating that axonal targeting information is en-
coded in NgCAM’s ectodomain (Sampo et al., 2003).
 
line), axonal (squares), uniform (triangles), or somatodendritic 
(circles) was determined. A transient somatodendritic population 
was observed at short times after the chase. At longer chase times, 
NgCAM accumulated in the axon.
Figure 5.
 
Kinetic analysis of NgCAM transport reveals a somato-
dendritic transport intermediate.
 
 (A) After infection with AdNgCAM, 
NgCAM was accumulated in the ER/Golgi compartment by an 
overnight treatment with BFA. Transport of the accumulated 
membrane proteins was then followed after removal of BFA by 
fixation at different time points and immunostaining according to 
the sandwich method to distinguish between surface and internal 
NgCAM pools. A representative cell expressing NgCAM with somato-
dendritic surface polarity 4 h after BFA washout is shown. The axon 
is marked by arrows, dendrites by arrowheads. (B) The appearance 
of the expressed proteins on the cell surface was counted (y axis) 
after BFA removal and scored as axonal (squares), uniform (triangles), 
or somatodendritic (circles). Cells with only internal staining were 
scored as not yet on surface (diamonds, stippled line). The quantita-
tion of a representative experiment is shown. This experiment was 
repeated independently more than five times. (C) Cells were infected 
with AdNgCAM for 6 h, shifted to 19
 
 
 
C for 12 h, and then shifted 
back to 37
 
 
 
C for various amounts of time. The percentage of cells 
expressing NgCAM either not yet on the surface (diamonds, stippled T
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To analyze whether NgCAM(CT3) still reaches the ax-
onal membrane via transcytosis, we studied the transport ki-
netics of NgCAM(CT3) using the BFA pulse-chase assay. In
contrast to full-length NgCAM, NgCAM(CT3) was never
detected on the somatodendritic surface (circles) after BFA
washout (Fig. 6 B). We first detected surface expression after
2 h of chase. Even at these earliest times of detectable surface
expression, NgCAM(CT3) was already axonally enriched on
the plasma membrane (Fig. 6 B, squares). Therefore, Ng-
CAM(CT3) appears to be directly delivered from the TGN
to the axonal plasma membrane. Therefore, both direct and
transcytotic axonal pathways exist.
 
The initial somatodendritic delivery of NgCAM 
requires the Y
 
33
 
RSL motif
 
Next, we asked which cytoplasmic tail sequences of NgCAM
are required for the initial somatodendritic insertion. Previ-
ously, the Y
 
33
 
RSL motif has been demonstrated to control
endocytosis of NgCAM through its interaction with the
clathrin adaptor complex AP-2 (Kamiguchi et al., 1998). In-
terestingly, tyrosine-based endocytosis signals are sometimes
colinear with tyrosine-based basolateral and/or somatoden-
dritic sorting signals (Matter et al., 1992, 1993, 1994).
To test the idea that the Y
 
33
 
RSL motif might be needed for
initial somatodendritic targeting before endocytosis, we gen-
erated a recombinant construct, NgCAM(Y33A), in which
the Y
 
33
 
RSL motif was disrupted by mutating tyrosine
 
33
 
 to
alanine (Fig. 2). Again, neuronal cultures were simulta-
neously infected with Adp75NGFR to visualize all processes
(Fig. 7 B). We found that NgCAM(Y33A) was well polar-
ized to the axon at steady state (Fig. 2; Fig. 7, A and B). To
determine how NgCAM(Y33A) arrived at the axon, we used
the BFA pulse-chase assay. Similarly to NgCAM(CT3), Ng-
CAM(Y33A) was enriched on the axonal plasma membrane
(Fig. 7 C, squares) even at the earliest times of detectable sur-
face expression. No somatodendritic population was ever ob-
served, suggesting transport via a direct pathway.
Transport along a direct pathway is expected to be inde-
pendent of endocytosis. We, therefore, tested whether
down-regulation of endocytosis would affect the axonal lo-
calization of NgCAM(Y33A) by coexpressing dynamin
(K44A) and NgCAM(Y33A). We found that axonal local-
ization of NgCAM(Y33A) was unaffected by coexpression of
dynamin(K44A) (Fig. 7 D), and therefore appeared inde-
pendent of endocytosis, consistent with direct routing to the
axon. Therefore, these data suggest that a mutation in the
Y
 
33
 
RSL motif prevents the initial somatodendritic delivery
of NgCAM and changes the axonal transport pathway from
transcytotic to direct. Therefore, the Y
 
33
 
RSL motif might
serve as a somatodendritic targeting determinant facilitating
the sorting of NgCAM at the TGN.
 
Discussion
 
A transcytotic model for NgCAM transport to the axon
 
The pathways and molecular mechanisms underlying polar-
ized membrane traffic in neurons are not well understood.
Several possible pathways for axonal enrichment of mem-
brane proteins have been proposed, among them selective
fusion with the axonal membrane (Sampo et al., 2003) or se-
lective removal from the somatodendritic domain (Garrido
et al., 2001). To determine how NgCAM travels to the
axon, we carefully investigated its trafficking pathway from
the TGN to the plasma membrane. Based on our findings,
we propose that NgCAM first inserts into the somatoden-
dritic domain (1) and, after endocytosis, (2) reaches somato-
dendritic early/recycling endosomes before the molecule
travels to the axon via transcytosis (3) (Fig. 8).
This model is based on the following evidence. When we
followed a pulse of NgCAM molecules leaving the TGN af-
ter a block with BFA or low temperatures, we observed ini-
Figure 6. The cytoplasmic tail of NgCAM is required for 
transcytotic delivery to the axon. (A) Hippocampal neurons 8–10 
DIV were infected with recombinant adenoviruses expressing 
NgCAM(CT3) for 30 h, fixed, and stained with mouse monoclonal 
antibodies against the extracellular domain of the virally expressed 
protein and detected with Alexa
®488-labeled goat anti–mouse 
secondary antibodies. To delineate all processes (soma region 
shown in inset), all cells were simultaneously infected with 
Adp75NGFR. Axons are marked with arrows, dendrites with 
arrowheads. (B) Transport kinetics of NgCAM(CT3) using the BFA 
block/release assay (see Fig. 4 legend). NgCAM(CT3) appears directly 
on the axonal surface.T
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tial appearance on the cell surface preferentially in the soma-
todendritic domain (Fig. 5). Furthermore, when endocytosis
was inhibited through overexpression of dominant-negative
dynamin1(K44A), axonal accumulation of NgCAM was sig-
nificantly blocked (Fig. 4). In cells expressing high levels of
dynamin1(K44A), NgCAM even accumulated at the soma-
todendritic domain instead. If however endocytosis was not
blocked, we detected internalized NgCAM in somatoden-
dritic early or recycling endosomes where it partially colocal-
ized with internalized transferrin (Fig. 3). At later time
points after the release of a TGN exit block, NgCAM was
chased to the axon (Fig. 5).
 
Multiple signals are required for transcytosis
 
NgCAM contains all the signals needed for a transcytotic
pathway: a somatodendritic and endocytosis signal colinear
with YRSL and an axonal targeting determinant in the extra-
cellular domain. To traverse a transcytotic pathway, these
signals presumably need to be read and executed sequentially
in different intracellular compartments: the somatodendritic
signal in the TGN, the endocytosis signal on the plasma
membrane, and the axonal signal in the endosome. How
 
cells accomplish this kind of hierarchical read-out of multi-
ple signals is not well understood for any protein. The best-
studied receptor undergoing transcytosis is the pIgR, which
carries dimeric IgA from the basolateral to the apical side of
epithelial cells (Mostov and Cardone, 1995). For pIgR,
ligand binding stimulates transcytosis several-fold in epithe-
lial cells (van Ijzendoorn et al., 2002). The same was found
for neurons (de Hoop et al., 1995). It has been suggested
that phosphorylation of a serine residue in the basolateral
sorting motif silences it and permits apical delivery from en-
dosomes (Casanova et al., 1990; Luton et al., 1998).
The molecular mechanisms underlying the transcytotic
pathway of NgCAM in neurons await further studies. In ep-
ithelial cells, NgCAM is enriched on the apical domain,
which it reaches also via transcytosis (unpublished data).
Here, sorting from the TGN to the basolateral membrane
domain is dependent on the clathrin adaptor AP-1B and the
sequence Y
 
33
 
RSL (unpublished data). However, as the adap-
tor complex AP-1B is not expressed in brain (Ohno et al.,
1999), another protein might be required for the somato-
dendritic sorting step of NgCAM in neurons. In neurons,
the disruption of the YRSL motif in NgCAM(Y33A) results
Figure 7. The YRSL motif is required for transcytosis. Neurons (8–10 DIV) were coinfected with AdNgCAM(Y33A) (A) and defective 
adenoviruses encoding the uniformly expressed p75/NGFR (B) for 30 h. NgCAM(Y33A) is axonally enriched (arrows mark axon, arrowheads 
mark dendrites). (C) Transport kinetics of NgCAM(Y33A) using the BFA block/release assay (see Fig. 4 legend). NgCAM(Y33A) appears directly 
on the axonal surface. (D) Quantitation of NgCAM(Y33A) polarization in neurons that are (gray bars; DNdynamin) or are not (black bars; control) 
expressing dominant-negative dynamin(K44A). A representative experiment is shown.T
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in a mutant protein that now travels on a direct route and
not via transcytosis (Fig. 7). This suggests that when the
YRSL motif is present, the axonal targeting information
contained within NgCAM’s ectodomain cannot be executed
in the TGN. How is the somatodendritic sorting signal si-
lenced subsequently in the endosome to allow for axonal de-
livery of the full-length protein? Recently, Schaefer et al.
(2002) demonstrated that the YRSL motif can be phosphor-
ylated by src, which inhibits AP-2 binding. Such a phos-
phorylation event might similarly inhibit binding of other
sorting adaptors, such as AP-1B. The YRSL motif might
also bind to additional proteins (Dickson et al., 2002)
whose interactions might be regulated by phosphorylation.
Therefore, the phosphorylation of YRSL may silence its so-
matodendritic sorting information, allowing the phosphory-
lated protein to travel to the axon instead.
A different model for axonal transport of NgCAM has
been proposed recently (Sampo et al., 2003). Sampo et al.
(2003) tested whether NgCAM’s polarization to the axonal
plasma membrane arises from axonally restricted fusion of
NgCAM-containing vesicles by assaying somatodendritic
endocytosis of anti-NgCAM antibodies. Somatodendritic
endocytosis of NgCAM could be observed, but only in a
small subpopulation of neurons. The neurons with detect-
able somatodendritic endocytosis of NgCAM were described
as looking less mature (Sampo et al., 2003). We similarly de-
tected somatodendritic endocytosis of NgCAM, albeit in a
very substantial proportion of the neurons (
 
 
 
50%). Why is
somatodendritic endocytosis not seen in all neurons? Soma-
todendritic uptake might still take place in those cells but
not be readily detectable. We did not notice any obvious
correlation between cells with detectable somatodendritic
endocytosis and axonal lengths, which might have indicated
that different pathways operate in immature and mature
cells. Rather, it appeared to us that somatodendritic endocy-
tosis was more readily detectable in cells with higher levels of
NgCAM on the axonal surface. Low levels of newly synthe-
sized NgCAM, and thus low levels of NgCAM on the soma-
todendritic surface at steady-state, and/or more rapid en-
docytic flux might account for the population of cells in
which somatodendritic endocytosis was undetectable.
In our kinetic assays, we observe 
 
 
 
90% of expressing neu-
rons trafficking NgCAM via the somatodendritic surface.
We therefore consider it likely that the relatively high pro-
portion of neurons where somatodendritic endocytosis is
undetectable can be attributed to technical limitations of the
sensitivity of detection rather than to pathway heterogeneity
in different neuronal populations. However, we cannot at
this point completely rule out the possibility that different
populations of cells, either less mature or of a different neu-
ronal cell type, traffic NgCAM by distinct pathways to the
axon. This could be regulated, for example, by differential
phosphorylation of NgCAM’s YRSL motif or some other
mechanism and lead to developmental or cell type–specific
regulation of pathway choice. More work needs to be done
to explore these potentially exciting possibilities.
The cytoplasmic YRSL sequence has previously been iden-
tified as an axonal targeting motif of L1/NgCAM. Kamigu-
chi and Lemmon (1998) found that mutations in the YRSL
motif lead to an accumulation of L1 in neurites of dorsal
root ganglion neurons (rather than just somata). In hippo-
campal neurons, however, NgCAM with a mutation in the
YRSLE motif did not accumulate in dendrites but was in-
stead routed directly into the axon (Fig. 7). These observa-
tions raise the interesting possibility that different neurons
may differ in the ways they process sorting signals of mem-
brane proteins. Dorsal root ganglion neurons may sort all
membrane proteins by default from the TGN to the soma-
Figure 8. A model for axonal transport of 
NgCAM. NgCAM (blue bars) travels on an 
indirect transcytotic route from the TGN 
(located in the soma) to the axon. The transcy-
totic indirect route consists of at least three steps: 
(1) TGN to somatodendritic plasma membrane, 
(2) somatodendritic plasma membrane to endo-
somes, and (3) endosome to axonal plasma 
membrane. Endocytosis is a necessary step for 
axonal delivery of NgCAM in this model.T
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todendritic domain and sort axonal and somatodendritic
proteins away from each other only in the endocytic system,
as is the case for hepatocytes. In contrast, hippocampal neu-
rons, like MDCK cells, possess the ability to sort newly syn-
thesized proteins already in the TGN.
 
Multiple pathways to the axons
 
Whether the majority of axonal membrane proteins travel
to the axon primarily by a direct, a transcytotic, or a prefer-
ential retrieval pathway requires the study of more axonal
proteins. Given that NgCAM travels transcytotically to the
apical domain in MDCK cells (unpublished data), a minor
pathway for apical proteins in MDCK cells, it is possible
that most axonal proteins do not follow a transcytotic
pathway in neurons. Could the transcytotic routing of Ng-
CAM be of physiological significance? Interestingly, analy-
sis of L1 knockout mice uncovered morphological abnor-
malities in the dendrites of some neuronal populations
(Demyanenko et al., 1999). Therefore our discovery that a
transcytotic pathway exists for NgCAM might be physio-
logically relevant, and the transient appearance of L1/Ng-
CAM on the dendritic surface might play an important
functional role.
 
Materials and methods
 
Reagents
 
The following adenoviruses were provided: AdNgCAM by P. Sonderegger
(ETH Zurich, Zurich, Switzerland), AdHA-dynamin(K44A) by J. Pessin (Uni-
versity of Iowa, Iowa City, IA), and Adp75NGFR by M. Chao (New York
University Medical School, New York, NY). The following antibodies were
used: anti-NgCAM monoclonal antibody 8D9 from National Institutes of
Health (NIH) hybridoma bank and anti-HA monoclonal antibody HA.11
from Babco. Rabbit antibody 9992 against the intracellular domain of
p75NGFR was provided by M. Chao. FITC–transferrin and Alexa
 
®
 
-conju-
gated secondary antibodies were from Molecular Probes. Cy3-, Cy5-, and
RRX-conjugated and unconjugated Fab fragments and IgGs were from Jack-
son ImmunoResearch Laboratories. BFA was from Epicentre Technologies.
 
Cell culture
 
Hippocampal cultures were prepared essentially as previously described
(Winckler et al., 1999). In brief, embryonic day 18 rat hippocampi were
dissected, dissociated by trituration after trypsin digestion, and plated on
polylysine-coated coverslips. After 4 h, the cells were transferred into se-
rum-free medium supplemented with B27 (GIBCO BRL) and cultured for
8–12 d. 293 cells were grown in DME with 10% FCS and 1% glutamine
for adenoviral production.
 
Construction of adenoviral vectors
 
The gene encoding full-length NgCAM (variant) (GenBank/EMBL/DDBJ ac-
cession no. Z75013) was provided by P. Sonderegger. To generate Ng-
CAM truncations, this gene was amplified by PCR using the oligonucle-
otides NgC25 (5
 
 
 
–GCGC
 
CTCGAG
 
ATGGCTCTGCCCCATGGG-3
 
 
 
) and
NgC17 (5
 
 
 
–CGCG
 
TCTAGA
 
TTAATCCAGGGGGGGCCC-3
 
 
 
), and cloned
into the pCR-XL-TOPO vector of the Invitrogen TOPO
 
®
 
 XL PCR Cloning
Kit according to the manufacturer’s instructions. The gene was then sub-
cloned into the mutagenesis and expression vector pAlter-MAX (Promega)
using the introduced XhoI and XbaI sites. The NgCAM truncation CT3 was
generated by single-primer mutagenesis according to the manufacturer’s
instructions using the oligonucleotides CT3 (5
 
 
 
-GTCCTTCACCGAATA-
CTTGCCCCC
 
TCTAGA
 
TTAGCTGCGTTTGATGAAGCAGAGGATG-3
 
 
 
) and
Y33A (5
 
 
 
-CTCCTCCGCTTCGCTCTCCAACGACCTGGCCTCCCCAAAG-
GTCTCATCCTTCATGGGCC-3
 
 
 
). The mutagenized constructs were cloned
into the pShuttleCMV vector using the introduced XhoI and XbaI sites.
Recombinant adenoviruses were subsequently generated using the
AdEasy system from Qbiogene according to the manufacturer’s instruc-
tions. In all oligonucleotides shown, the sequences complementary to the
NgCAM sequence are underlined, and introduced restriction sites are
shown in bold.
 
Adenoviral infection
 
Hippocampal cultures grown on glass coverslips were moved to 12-well
plates in 500 
 
 
 
l conditioned medium in the presence of 1 mM kynurenic
acid, and 1–5 
 
 
 
l of purified adenovirus was added per well. After 4 h, 500
 
 
 
l of conditioned medium was added, and cells were incubated for 24–36 h.
As we use the same antibodies to detect the expressed proteins, we note
that the range of staining intensities found in a population of expressing
neurons is comparable between different constructs.
 
BFA block/release
 
Cells were infected as described above. After 4 h, BFA (Epicentre Technol-
ogies) was added to 0.5–0.75 
 
 
 
g/ml final concentration. After 12–18 h,
coverslips were washed twice in conditioned medium and transferred to
fresh dishes. Coverslips were removed and fixed at indicated times and
stained by the sandwich technique described below. The sandwich stain-
ing allowed counting of cells that were infected (i.e., positive for intracel-
lular NgCAM) but where the protein had not reached the surface yet (i.e.,
negative for surface staining). We observe that the kinetics of surface trans-
port are somewhat variable between cultures and appear slower for older
cultures (12 days in vitro [DIV]) than for younger (8 DIV). All experiments
were performed at least three independent times.
 
Immunofluorescence
 
Cells were fixed in 2% paraformaldehyde/3% sucrose/PBS in 50% condi-
tioned medium at room temperature for 30 min and quenched in 10 mM
glycine/PBS for 10 min. Alternatively, 2% paraformaldehyde/3% sucrose/
0.125% glutaraldehyde/PBS was used in some experiments. The fixation
conditions used do not introduce holes into most cells (not depicted). Cov-
erslips were then blocked in 5% horse serum/1% BSA/PBS in the presence
or absence of 0.05% saponin for 30 min. Antibodies were diluted in 1%
BSA/PBS with or without 0.05% saponin and incubated for 1–2 h. Cover-
slips were mounted in Vectashield (Vector labs) and viewed on a Carl Zeiss
MicroImaging, Inc. Axiophot with a 40
 
 
 
 objective. Images were captured
with the Orca cooled CCD camera (Hamamatsu) using Openlab software
(ImproVision) and processed identically in Adobe Photoshop
 
®
 
. For surface
staining, live cells were incubated for 5 min at room temperature in pri-
mary antibody before fixation and incubation with secondary antibodies.
 
Quantification of polarized distribution
 
Localization was quantified essentially as published elsewhere (Sampo et
al., 2003). In brief, lines were traced along multiple segments of axons
(8–10 segments covering most of the axon) and dendrites (along entire
lengths of each dendrite), and average pixel intensities were determined
along the traced lines. The intensities of all axonal and all dendritic seg-
ments were averaged. The average background intensity of uninfected
cells was determined and subtracted from the axonal and dendritic inten-
sity values. A PI was calculated by dividing the axonal by the dendritic av-
erage pixel intensities. Uniform staining gives a PI value of around 1. Pref-
erential axonal staining gives a PI value of 
 
 
 
1, whereas preferential
somatodendritic enrichment gives a PI value of 
 
 
 
1. The PI of 5–10 cells
was determined for each construct and averaged.
 
Sandwich staining
 
To visualize the internal and surface population of NgCAM separately, a
protocol similar to that published by Kamiguchi and Lemmon (2000) was
used with modifications. In brief, cells were fixed, blocked, and incubated
with primary antibody as described above. The primary antibody was de-
tected with FITC–G
 
 
 
M Fab fragments (Jackson ImmunoResearch Laborato-
ries). Any unbound primary antibodies were subsequently blocked with
unconjugated G
 
 
 
M Fab fragments (1 mg/ml) for 1 h to overnight and fixed
for 10 min. Cells were then permeabilized in 0.05% saponin/1% BSA/PBS
for 30 min and incubated with a second round of primary antibodies. This
second round of antibodies was detected with rhodamine red–labeled goat
anti–mouse secondary antibodies (Jackson ImmunoResearch Laboratories).
This protocol leads to separable staining of internal and external popula-
tions in all cells except very highly overexpressing cells. In those cases, the
surface could not be completely blocked with unconjugated Fab fragments
even at much higher concentrations.
 
Endocytosis assay
 
Cells were incubated in transferrin-free medium (Bottenstein and Sato
N2.1 medium minus transferrin) for 1 h. FITC–transferrin (Molecular
Probes) at 0.2 mg/ml was added simultaneously with anti-NgCAM anti-
bodies (0.3 mg/ml) for 30 min at 37
 
 
 
C. After fixation, surface and internal-
ized NgCAM were visualized using the sandwich protocol, except primaryT
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antibody was omitted. Images were taken on a Leica TCS-SP confocal mi-
croscope. Uptake of antibody was mediated specifically by the virally ex-
pressed receptor molecules, as uninfected cells show no uptake even after
2 h of incubation with anti-NgCAM antibodies. The 8D9 antibody does
not detect the endogenous rat L1. Binding of antibodies to live cells can in
some cases cause either inhibition of endocytosis or transport to lyso-
somes. Neither is the case for NgCAM expressed in hippocampal neurons
(not depicted). To determine overlap of internalized NgCAM and FITC–
transferrin, a threshold function was applied in Adobe Photoshop
 
®
 
. For
each channel, the threshold level was chosen such that very small and
very faint puncta disappeared. Our procedure erred on the side of underes-
timating overlap between the two tracers. All pixel intensities above this
threshold level were set to 255.
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